Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2025

Maternal Pertussis Vaccine for Newborn Protection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Maternal Pertussis Vaccine for Newborn Protection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Maternal Pertussis Vaccine for Newborn Protection production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Maternal Pertussis Vaccine for Newborn Protection is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Maternal Pertussis Vaccine for Newborn Protection in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.

The global Maternal Pertussis Vaccine for Newborn Protection market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The Maternal Pertussis Vaccine for Newborn Protection industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for Maternal Pertussis Vaccine for Newborn Protections is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Maternal Pertussis Vaccine for Newborn Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maternal Pertussis Vaccine for Newborn Protection.

The Maternal Pertussis Vaccine for Newborn Protection market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, by Composition and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Maternal Pertussis Vaccine for Newborn Protection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Composition and by regions.

Scope of Maternal Pertussis Vaccine for Newborn Protection Market Report

Core Chapters

1.1 Product Definition

1.2 Maternal Pertussis Vaccine for Newborn Protection by Type

1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024 VS 2031)

1.2.2 DTaP

1.2.3 Tdap

1.2.4 DTwP

1.3 Maternal Pertussis Vaccine for Newborn Protection by Composition

1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Composition: 2024 VS 2031

1.3.2 Acellular Vaccines

1.3.3 Whole-cell Vaccines

1.4 Maternal Pertussis Vaccine for Newborn Protection by User

1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by User: 2024 VS 2031

1.4.2 Below 12 Months

1.4.3 Above 12 Months

1.5 Maternal Pertussis Vaccine for Newborn Protection by Application

1.5.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024 VS 2031)

1.5.2 Hospital

1.5.3 Clinic

1.6 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts

1.6.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue 2020-2031

1.6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales 2020-2031

1.6.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Average Price (2020-2031)

1.7 Assumptions and Limitations

2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application

2.7 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Enter into This Industry

2.8 Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends

2.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue

2.8.3 Global Maternal Pertussis Vaccine for Newborn Protection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2020-2031

3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2020-2025

3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2026-2031

3.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020-2031

3.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020-2025

3.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2026-2031

3.4 North America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country

3.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)

3.4.3 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country

3.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)

3.5.3 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Region

3.6.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2031)

3.6.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country

3.7.1 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)

3.7.3 Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country

3.8.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2031)

4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2020-2025)

4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2026-2031)

4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2031)

4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2031)

4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2020-2025)

4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2026-2031)

4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2020-2031)

4.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2020-2031)

5.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2031)

5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2020-2025)

5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2026-2031)

5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2031)

5.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2031)

5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2020-2025)

5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2026-2031)

5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2020-2031)

5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2020-2031)

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Company Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GSK Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Mitsubishi Tanabe Pharma

6.3.1 Mitsubishi Tanabe Pharma Company Information

6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.3.3 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.4 KM Biologics

6.4.1 KM Biologics Company Information

6.4.2 KM Biologics Description and Business Overview

6.4.3 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.4.5 KM Biologics Recent Developments/Updates

6.5 Wuhan Institute of Biological Products

6.5.1 Wuhan Institute of Biological Products Company Information

6.5.2 Wuhan Institute of Biological Products Description and Business Overview

6.5.3 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates

6.6 Walvax Biotechnology

6.6.1 Walvax Biotechnology Company Information

6.6.2 Walvax Biotechnology Description and Business Overview

6.6.3 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.6.5 Walvax Biotechnology Recent Developments/Updates

6.7 Chengdu Institute of Biological Products

6.7.1 Chengdu Institute of Biological Products Company Information

6.7.2 Chengdu Institute of Biological Products Description and Business Overview

6.7.3 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates

6.8 Minhai Biotechnology

6.8.1 Minhai Biotechnology Company Information

6.8.2 Minhai Biotechnology Description and Business Overview

6.8.3 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Portfolio

6.8.5 Minhai Biotechnology Recent Developments/Updates

7.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis

7.2 Maternal Pertussis Vaccine for Newborn Protection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process Analysis

7.4 Maternal Pertussis Vaccine for Newborn Protection Sales and Marketing

7.4.1 Maternal Pertussis Vaccine for Newborn Protection Sales Channels

7.4.2 Maternal Pertussis Vaccine for Newborn Protection Distributors

7.5 Maternal Pertussis Vaccine for Newborn Protection Customer Analysis

8.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends

8.2 Maternal Pertussis Vaccine for Newborn Protection Market Drivers

8.3 Maternal Pertussis Vaccine for Newborn Protection Market Challenges

8.4 Maternal Pertussis Vaccine for Newborn Protection Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

 Table 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition, (US$ Million) & (2024 VS 2031)

 Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User, (US$ Million) & (2024 VS 2031)

 Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2024 VS 2031) & (US$ Million)

 Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation by Manufacturers in 2024

 Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) of Key Manufacturers (2020-2025)

 Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2020-2025)

 Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Manufacturers (2020-2025)

 Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2020-2025)

 Table 10. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) of Key Manufacturers (2020-2025)

 Table 11. Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2022 VS 2023 VS 2024

 Table 12. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters

 Table 13. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application

 Table 14. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Enter into This Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Maternal Pertussis Vaccine for Newborn Protection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Maternal Pertussis Vaccine for Newborn Protection as of 2024)

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K Dose)

 Table 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2025)

 Table 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2026-2031) & (K Dose)

 Table 22. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2026-2031)

 Table 23. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2025) & (US$ Million)

 Table 24. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2025)

 Table 25. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2026-2031) & (US$ Million)

 Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2026-2031)

 Table 27. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 28. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K Dose)

 Table 29. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (K Dose)

 Table 30. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)

 Table 31. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)

 Table 32. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K Dose)

 Table 34. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (K Dose)

 Table 35. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)

 Table 36. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)

 Table 37. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

 Table 38. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2020-2025) & (K Dose)

 Table 39. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2026-2031) & (K Dose)

 Table 40. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2020-2025) & (US$ Million)

 Table 41. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2026-2031) & (US$ Million)

 Table 42. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 43. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K Dose)

 Table 44. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (K Dose)

 Table 45. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)

 Table 46. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)

 Table 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 48. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025) & (K Dose)

 Table 49. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2026-2031) & (K Dose)

 Table 50. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2020-2025) & (US$ Million)

 Table 51. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2026-2031) & (US$ Million)

 Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Type (2020-2025)

 Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Type (2026-2031)

 Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2020-2025)

 Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2026-2031)

 Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2020-2025)

 Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2026-2031)

 Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2020-2025)

 Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2026-2031)

 Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2020-2025)

 Table 61. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2026-2031)

 Table 62. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Application (2020-2025)

 Table 63. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Application (2026-2031)

 Table 64. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2020-2025)

 Table 65. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2026-2031)

 Table 66. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2020-2025)

 Table 67. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2026-2031)

 Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2020-2025)

 Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2026-2031)

 Table 70. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2020-2025)

 Table 71. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2026-2031)

 Table 72. Sanofi Pasteur Company Information

 Table 73. Sanofi Pasteur Description and Business Overview

 Table 74. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 75. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product

 Table 76. Sanofi Pasteur Recent Developments/Updates

 Table 77. GSK Company Information

 Table 78. GSK Description and Business Overview

 Table 79. GSK Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 80. GSK Maternal Pertussis Vaccine for Newborn Protection Product

 Table 81. GSK Recent Developments/Updates

 Table 82. Mitsubishi Tanabe Pharma Company Information

 Table 83. Mitsubishi Tanabe Pharma Description and Business Overview

 Table 84. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 85. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product

 Table 86. Mitsubishi Tanabe Pharma Recent Developments/Updates

 Table 87. KM Biologics Company Information

 Table 88. KM Biologics Description and Business Overview

 Table 89. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 90. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product

 Table 91. KM Biologics Recent Developments/Updates

 Table 92. Wuhan Institute of Biological Products Company Information

 Table 93. Wuhan Institute of Biological Products Description and Business Overview

 Table 94. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 95. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product

 Table 96. Wuhan Institute of Biological Products Recent Developments/Updates

 Table 97. Walvax Biotechnology Company Information

 Table 98. Walvax Biotechnology Description and Business Overview

 Table 99. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 100. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product

 Table 101. Walvax Biotechnology Recent Developments/Updates

 Table 102. Chengdu Institute of Biological Products Company Information

 Table 103. Chengdu Institute of Biological Products Description and Business Overview

 Table 104. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 105. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product

 Table 106. Chengdu Institute of Biological Products Recent Developments/Updates

 Table 107. Minhai Biotechnology Company Information

 Table 108. Minhai Biotechnology Description and Business Overview

 Table 109. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

 Table 110. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product

 Table 111. Minhai Biotechnology Recent Developments/Updates

 Table 112. Key Raw Materials Lists

 Table 113. Raw Materials Key Suppliers Lists

 Table 114. Maternal Pertussis Vaccine for Newborn Protection Distributors List

 Table 115. Maternal Pertussis Vaccine for Newborn Protection Customers List

 Table 116. Maternal Pertussis Vaccine for Newborn Protection Market Trends

 Table 117. Maternal Pertussis Vaccine for Newborn Protection Market Drivers

 Table 118. Maternal Pertussis Vaccine for Newborn Protection Market Challenges

 Table 119. Maternal Pertussis Vaccine for Newborn Protection Market Restraints

 Table 120. Research Programs/Design for This Report

 Table 121. Key Data Information from Secondary Sources

 Table 122. Key Data Information from Primary Sources

 Table 123. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection

 Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type: 2024 & 2031

 Figure 4. DTaP Product Picture

 Figure 5. Tdap Product Picture

 Figure 6. DTwP Product Picture

 Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition, (US$ Million) & (2020-2031)

 Figure 8. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Composition: 2024 VS 2031

 Figure 9. Acellular Vaccines Product Picture

 Figure 10. Whole-cell Vaccines Product Picture

 Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User, (US$ Million) & (2020-2031)

 Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by User: 2024 VS 2031

 Figure 13. Below 12 Months Product Picture

 Figure 14. Above 12 Months Product Picture

 Figure 15. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (2020-2031) & (US$ Million)

 Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application: 2024 & 2031

 Figure 17. Hospital

 Figure 18. Clinic

 Figure 19. Global Maternal Pertussis Vaccine for Newborn Protection Revenue, (US$ Million), 2020 VS 2024 VS 2031

 Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (2020-2031) & (US$ Million)

 Figure 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales (2020-2031) & (K Dose)

 Figure 22. Global Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) & (2020-2031)

 Figure 23. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered

 Figure 24. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2024

 Figure 25. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2024

 Figure 26. Global 5 and 10 Largest Maternal Pertussis Vaccine for Newborn Protection Players: Market Share by Revenue in Maternal Pertussis Vaccine for Newborn Protection in 2024

 Figure 27. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

 Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Figure 29. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)

 Figure 30. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)

 Figure 31. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 32. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)

 Figure 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)

 Figure 35. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 36. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 37. U.K. Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 38. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 39. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 40. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2020-2031)

 Figure 41. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2020-2031)

 Figure 42. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 43. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 44. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 45. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 46. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 47. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 48. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 49. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)

 Figure 50. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)

 Figure 51. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 52. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 53. Argentina Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 54. Colombia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 55. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2020-2031)

 Figure 56. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2020-2031)

 Figure 57. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 58. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 59. UAE Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 60. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2031)

 Figure 61. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2020-2031)

 Figure 62. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2020-2031)

 Figure 63. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2020-2031)

 Figure 64. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2020-2031)

 Figure 65. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2020-2031)

 Figure 66. Maternal Pertussis Vaccine for Newborn Protection Value Chain

 Figure 67. Channels of Distribution (Direct Vs Distribution)

 Figure 68. Bottom-up and Top-down Approaches for This Report

 Figure 69. Data Triangulation

 Figure 70. Key Executives Interviewed